ravi salgia, md, phd, on treatment in the 2nd line setting after 1st line pd-l1 targeting agents
Published 5 years ago • 31 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
0:57
ravi salgia, md, phd, outlines some of the molecular tests utilized prior to treating advanced nsclc
-
0:48
ravi salgia, md, phd, considers the unmet medical needs in the treatment of nsclc
-
1:35
meet medical oncologist and chair ravi salgia, m.d., ph.d. | city of hope
-
0:22
2020 west oncology conference - ravi salgia, md | key takeaways from the immunotherapy discussion
-
1:45
dr. ravi salgia describes molecular applications in advanced lung cancer
-
![spm - klinik spm - kanser paru – paru [1 nov 2016]](https://i.ytimg.com/vi/EhC0BpxLzR4/mqdefault.jpg)
14:22
spm - klinik spm - kanser paru – paru [1 nov 2016]
-
2:49
welcome to lci gi oncology
-
30:17
immunotherapy's next wave - transforming cancer care
-
0:43
ravi salgia, md, phd | what's exciting about lung cancer at 2018 best of asco st. louis
-
17:03
don wilson lecture: expanding endotherapy options by early gi cancer by thomas rösch
-
0:48
dr. salgia on next-generation sequencing in lung cancer
-
2:43
cancer patients given access to genomic testing for accurate diagnosis
-
1:07
robert sinha, md - radiation oncology | el camino health
-
2:47
health dg advocates integrative medicine for malaysian healthcare reform
-
2:10
rlt-psma in development
-
3:16
ravi sureddi md
-
1:20
spms now: role of resolvins in cancer
-
2:23
meet parag sanghvi, md, msph: radiation oncologist
-
8:33
sglt2 inhibitors - md/dnb general medicine
-
3:37
colorectal cancer: what is it?